Abstract Th0023: Alleviating radiation-induced cardiovascular disease with a radioprotective fullerene derivative

Despite modern radiation therapy (RT) advancements, radiation-induced cardiovascular (CV) disease still remains a significant cause of morbidity and mortality among cancer patients. Reactive oxygen species (ROS) cause oxidative damage to biomolecules such as DNA, lipids, and proteins, which play a key role in promoting radiation-induced cell injury. Endothelial cells (ECs) injured by RT contribute to the development and progression of CV disease. Reducing ROS injury can be a promising strategy to alleviate the harmful effects of RT. Fullerenes and their derivatives are potent antioxidants, often referred to as "free radical scavengers" because of their electron-deficient structure and their ability to readily interact with and neutralize free radicals. Despite promising reports of the antioxidant and anti-inflammatory activity of C60 fullerenes in recent years, the greatest challenge for translating them to the clinic is their inherent lipophilicity and insolubility in aqueous media. We have developed a novel chemistry for custom-synthesis of C60 fullerene derivatized with serinol (C 60 -ser) to make it amphiphilic in nature, creating a compound that is neutral and exquisitely soluble in water. Our data establish proof-of-principle that C 60 -ser is non-toxic and can protect non-malignant normal endothelial but not cancer cells, from RT-mediated damage. This radioprotection is exerted by scavenging RT-induced free radicals, amplifying anti-oxidant response pathways, and mitochondrial metabolic reprogramming. By reducing RT-induced ROS levels, C 60 -ser also inhibits DNA damage, apoptosis, senescence, and inflammatory responses within ECs. Successful translation of this clinically relevant radioprotective role for C 60 -ser could reduce RT-induced CV morbidity and mortality in cancer patients. Furthermore, inhibition of endothelial oxidative stress could have salutary effects across multiple endotheliopathies such that C 60 -ser may be a turn-key unified class solution to cardiovascular injury caused by various insults.

Authors

Institutions

Publication Details

Journal
Arteriosclerosis Thrombosis and Vascular Biology
Published
2025-04-01
DOI
https://doi.org/10.1161/atv.45.suppl_1.th0023
Primary Topic
Anesthesia and Neurotoxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract Th0023: Alleviating radiation-induced cardiovascular disease with a radioprotective fullerene derivative

Sunil Krishnan, Khadijeh Koushki, Sivareddy Kotla
Arteriosclerosis Thrombosis and Vascular Biology
Anesthesia and Neurotoxicity Research
article

Abstract Th0023: Alleviating radiation-induced cardiovascular disease with a radioprotective fullerene derivative

Sunil Krishnan, Khadijeh Koushki, Sivareddy Kotla
article en

Abstract

Despite modern radiation therapy (RT) advancements, radiation-induced cardiovascular (CV) disease still remains a significant cause of morbidity and mortality among cancer patients. Reactive oxygen species (ROS) cause oxidative damage to biomolecules such as DNA, lipids, and proteins, which play a key role in promoting radiation-induced cell injury. Endothelial cells (ECs) injured by RT contribute to the development and progression of CV disease. Reducing ROS injury can be a promising strategy to alleviate the harmful effects of RT. Fullerenes and their derivatives are potent antioxidants, often referred to as "free radical scavengers" because of their electron-deficient structure and their ability to readily interact with and neutralize free radicals. Despite promising reports of the antioxidant and anti-inflammatory activity of C60 fullerenes in recent years, the greatest challenge for translating them to the clinic is their inherent lipophilicity and insolubility in aqueous media. We have developed a novel chemistry for custom-synthesis of C60 fullerene derivatized with serinol (C 60 -ser) to make it amphiphilic in nature, creating a compound that is neutral and exquisitely soluble in water. Our data establish proof-of-principle that C 60 -ser is non-toxic and can protect non-malignant normal endothelial but not cancer cells, from RT-mediated damage. This radioprotection is exerted by scavenging RT-induced free radicals, amplifying anti-oxidant response pathways, and mitochondrial metabolic reprogramming. By reducing RT-induced ROS levels, C 60 -ser also inhibits DNA damage, apoptosis, senescence, and inflammatory responses within ECs. Successful translation of this clinically relevant radioprotective role for C 60 -ser could reduce RT-induced CV morbidity and mortality in cancer patients. Furthermore, inhibition of endothelial oxidative stress could have salutary effects across multiple endotheliopathies such that C 60 -ser may be a turn-key unified class solution to cardiovascular injury caused by various insults.

Arteriosclerosis Thrombosis and Vascular BiologyVol. 45(Suppl_1)
The University of Texas Health Science Center at Houston (US)
Openalex Percentile: Top 84%
Anesthesia and Neurotoxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.